These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19703339)

  • 1. Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse.
    Rentzos M; Nikolaou C; Rombos A; Evangelopoulos ME; Dimitrakopoulos A; Kararizou E; Koutsis G; Zoga M; Tsoutsou A; Sfangos K
    Neurol Res; 2010 Sep; 32(7):684-9. PubMed ID: 19703339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
    Rentzos M; Nikolaou C; Rombos A; Evangelopoulos ME; Kararizou E; Koutsis G; Zoga M; Dimitrakopoulos A; Tsoutsou A; Sfangos C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):992-6. PubMed ID: 18657352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interleukin-16 and RANTES during treatment of Graves' orbitopathy with corticosteroids and teleradiotherapy.
    Mysliwiec J; Palyga I; Nikolajuk A; Kowalska A; Gorska M
    Endokrynol Pol; 2012; 63(2):92-6. PubMed ID: 22538746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating interleukin-15 and RANTES chemokine in Parkinson's disease.
    Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
    Acta Neurol Scand; 2007 Dec; 116(6):374-9. PubMed ID: 17986095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change of interleukin-4 and interleukin-12 levels after therapy of multiple sclerosis relapse with methylprednisolone].
    Bartosik-Psujek H; Magryś A; Montewka-Kozioł M; Stelmasiak Z
    Neurol Neurochir Pol; 2005; 39(3):207-12. PubMed ID: 15981158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone.
    Szczuciński A; Kalinowska A; Losy J
    Eur Neurol; 2007; 58(4):228-32. PubMed ID: 17827967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?
    Noris M; Daina E; Gamba S; Bonazzola S; Remuzzi G
    Circulation; 1999 Jul; 100(1):55-60. PubMed ID: 10393681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.
    Bartosik-Psujek H; Belniak E; Mitosek-Szewczyk K; Dobosz B; Stelmasiak Z
    Acta Neurol Scand; 2004 Jun; 109(6):390-2. PubMed ID: 15147461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment.
    Gamonal J; Acevedo A; Bascones A; Jorge O; Silva A
    J Periodontol; 2000 Oct; 71(10):1535-45. PubMed ID: 11063385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis].
    Kacprzyk F
    Pol Arch Med Wewn; 2002 Sep; 108(3):837-42. PubMed ID: 12600179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone).
    Losy J; Michałowska-Wender G; Kurdyńska A; Wender M
    Folia Neuropathol; 2005; 43(3):153-5. PubMed ID: 16245210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.
    Gangemi S; Basile G; Merendino RA; Epifanio A; Di Pasquale G; Ferlazzo B; Nicita-Mauro V; Morgante L
    Mediators Inflamm; 2003 Aug; 12(4):251-3. PubMed ID: 14514477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
    Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
    Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease.
    Bartosik-Psujek H; Stelmasiak Z
    Eur J Neurol; 2005 Jan; 12(1):49-54. PubMed ID: 15613147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of several chemokines in patients with rheumatoid arthritis].
    Wu HX; Zhang Y; Zhu YL
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):534-7. PubMed ID: 15949333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.
    Bartosik-Psujek H; Stelmasiak Z
    Eur Neurol; 2004; 52(4):237-41. PubMed ID: 15550762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
    Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C
    Mult Scler; 2015 Apr; 21(5):646-50. PubMed ID: 25145693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.